Bank of America reaffirmed their underperform rating on shares of Achilles Therapeutics (NASDAQ:ACHL – Free Report) in a report released on Thursday morning, Benzinga reports. Achilles Therapeutics Stock Up 1.2 % Shares of Achilles Therapeutics stock opened at $0.87 on Thursday. The firm’s 50 day moving average price is $0.86 and its 200-day moving average […]

Related Keywords

United States , America , , Achilles Therapeutics Company Profile , Balyasny Asset Management , Achilles Therapeutics Plc , America Corp , Virtu Financial , Renaissance Technologies , Sei Investments Co , Achilles Therapeutics , Free Report , Get Free Report , Asset Management , Therapeutics Plc , Achilles Therapeutics Daily , Nasdaq Achl , Bachl , Medical , Reiterated Rating , Bank Of America Co ,